In the study of Vrzalova et al. [42], using the same multiplex panel, only CA125, OPN and IGF-2 differed significantly between patients with malignant and benign tumors, while serum levels of MIF, PRL and leptin did not. This evidence concerns the gene IGF2 and benign neoplasm.